SlideShare a Scribd company logo
AmyloidosisAmyloidosis
Dr.CSBR.Prasad, M.D.
APR-2015-CSBRP
Gist - AMYLOID
• It’s only a manifestation of different diseases
• it’s an abnormal protein
• It’s deposited Extracellularly
• It’s bland and Non-reactive
• Enzyme resistant
• Affects all tissues
• It causes organ failure by pressure atrophy
APR-2015-CSBRP
Gist - AMYLOID
Two processes are associated with
such deposition
• Prolonged inflammation
• Excessive immunoglobulin synthesis
APR-2015-CSBRP
Amyloid
Amyloid is a pathologic proteinaceous
substance, deposited between cells in
various tissues and organs of the body in
a wide variety of clinical settings.
APR-2015-CSBRP
AmyloidAmyloid
With the light microscope and standard
tissue stains, amyloid appears as
• An amorphous, eosinophilic, hyaline
like, extracellular substance
APR-2015-CSBRP
DD Hyaline & Amyloid
FeatureFeature HyalineHyaline AmyloidAmyloid
Location Both extra & intracellular Extracellular
Nature Protein / others Protein
Inflammation Inflammatory reaction No inflammation
Etiology Variety of agents Immunological
H&E Eosinophilic Eosinophilic
Congo red Negative Positive
CR+Polarizer No change Apple green
EM variety of morphology Nonbranching fibrils
APR-2015-CSBRP
Amyloid
• Is not a single protein
• Chemically different proteins with
identical staining properties
APR-2015-CSBRP
Amyloid – Physical nature
By electron microscopy:By electron microscopy:
(It’s common to all amyloid proteins(It’s common to all amyloid proteins))
• Non-branching fibrils
• Diameter of 7.5-10 nm
• cross-β-pleated sheet conformation
This β-pleated nature is responsible for its
special staining character
APR-2015-CSBRP
Amyloid – Physical nature
APR-2015-CSBRP
The Nature of Amyloid
Ultrastructure
Structure of an amyloid fibril
APR-2015-CSBRP
Amyloid – Chemical nature
Mainly composed of:
1. Fibrillary protein - 95%
2. P-component - 5%
3. Glycoprotein - a fraction
APR-2015-CSBRP
gist - The Nature of Amyloid
• Physical Nature:
• Electron microscopy: Amyloid material contains two
components. (1) Rigid nonbranching fibrils* (7.5 to 10 nm):
Constitute the major component (about 90%) (2) Pentagonal
rod shaped sub-unit (P components): Forms 10% of amyloid
tissue and is a glycoprotein (variable PAS positive staining).
• X-ray diffraction analysis: Characteristic β-pleated
configuration* in both major subtypes of amyloid.
• Chemical nature:
• Peptide mapping analysis of the sequence of amino
acids: Of the 15 biochemically distinct forms
identified, 3 are major chemical types of amyloid: (1) Amyloid
of light chain origin (AL) from plasma cells, (2) Unique
nonimmunoglobulin protein synthesized in the liver (AA), (3)
Aβ amyloid in cerebral lesion of Alzheimer disease
APR-2015-CSBRP
Classification
Amyloid may be:Amyloid may be:
Systemic (generalized), involving several
organ systems, or
Localized, when deposits are limited to a
single organ, such as the Heart, Skin et.c.
APR-2015-CSBRP
Localized Amyloid Deposits
Endocrine associated:
• Amyloid deposits in the stroma of medullary thyroid carcinoma, a C-
cell tumor; amyloid is derived from a polypeptide hormone calcitonin.
• Amyloid deposits in the stroma of islet cell tumors, particularly those
producing insulin (amyloid is produced by proteolysis of insulin or its
prohormone).
Senile amyloidosis:
• Deposits are common in the aged (seventies and eighties); found in
heart (atria affected more frequently than ventricles) and brain (as
senile plaques).
• The plaques found in Alzheimers disease is derived from β-amyloid
protein (Aβ), derived from a glycoprotein called amyloid precursor
protein (APP).
Other localized deposits: Microscopic deposits to nodular
masses in sites such as lung, larynx, skin, bladder, and tongue.
Consist of AL protein in most cases.
APR-2015-CSBRP
Clinicopathologic Category
Associated Diseases
Major Fibril
Protein
Chemically Related
Precursor Protein
Systemic (Generalized) Amyloidosis
Immunocyte dyscrasias with
amyloidosis (primary amyloidosis)
Multiple myeloma and other
monoclonal B-cell proliferations
AL
Immunoglobulin light
chains, chiefly λ type
Reactive systemic amyloidosis
(secondary amyloidosis)
Chronic inflammatory conditions AA SAA
Hemodialysis-associated
amyloidosis
Chronic renal failure Aβ2
m β2
-microglobulin
Hereditary amyloidosis
Familial Mediterranean fever — AA SAA
Familial amyloidotic neuropathies
(several types)
— ATTR Transthyretin
Systemic senile amyloidosis — ATTR Transthyretin
Localized Amyloidosis
Senile cerebral Alzheimer disease Aβ APP
Endocrine
Medullary carcinoma of thyroid — A Cal Calcitonin
Islet of Langerhans Type II diabetes AIAPP Islet amyloid peptide
Isolated atrial amyloidosis — AANF Atrial natriuretic factor
Prion diseases
Various prion diseases of the
CNS
Misfolded prion
protein (PrPSC
)
Normal prion protein
PrP
APR-2015-CSBRP
Classification of Systemic AmyloidosisClassification of Systemic Amyloidosis
on clinical groundson clinical grounds
• Primary amyloidosis, when associated with
some immunocyte dyscrasia, or
• Secondary amyloidosis, when it occurs as a
complication of an underlying chronic
inflammatory or tissue destructive process.
• Hereditary or familial amyloidosis constitutes a
separate, albeit heterogeneous group, with
several distinctive patterns of organ
involvement.
• Hemodialysis associated Amyloidosis
• Localized amyloidosis - (A). Endocrine
associated, (B). Senile, and (C). Others
APR-2015-CSBRP
Immunocyte Dyscrasias with
Amyloidosis (Primary Amyloidosis)
• Most common form of amyloidosis
• many of these patients have some form of
plasma cell dyscrasia / B-cell dyscrasia
• Amyloid has AL composition
APR-2015-CSBRP
Reactive Systemic Amyloidosis
• Secondary to an inflammatory condition
• Protracted breakdown of cells
• Composed of AA protein
Chronic osteomyelitis Rheumatoid arthritis
Bronchiectasis Connective tissue disease
Tuberculosis RCC
Leprosy Hodgkin’s disease
APR-2015-CSBRP
Patients on long-term hemodialysis for renal failure
High β2-microglobulin in the serum
Amyloid deposits in the synovium, joints, and
tendon sheaths
Hemodialysis-Associated
Amyloidosis
APR-2015-CSBRP
• Many familial forms of amyloidosis
• Confined to limited geographic areas
• The most common is familial Mediterranean fever
• Others - familial amyloidotic polyneuropathies
Heredofamilial Amyloidosis
APR-2015-CSBRP
Microscopic localized deposits of amyloid in
endocrine tumors,
Eg: Medullary carcinoma of the thyroid gland,
Islet tumors of the pancreas
Pheochromocytomas and
Undifferentiated carcinomas of the stomach
Amyloid derived from hormones or unique proteins
Endocrine Amyloid
APR-2015-CSBRP
Several well-documented forms of amyloid
deposition occur with aging
Senile systemic amyloidosis - systemic
deposition of amyloid in elderly patients
called senile cardiac amyloidosis
Amyloid of Aging
APR-2015-CSBRP
Amyloid – Chemical nature
Fibrillary component: 15 bio-chemically distinct
forms have been identified
Three are most common:
(1) AL (amyloid light chain) immunoglobulin light
chains
(2) AA (amyloid-associated) nonimmunoglobulin
protein synthesized by the liver and
(3) Aβ amyloid is found in Alzheimer disease
APR-2015-CSBRP
Proposed Scheme of Pathogenesis of Two
Major Forms of Amyloid Fibrils
APR-2015-CSBRP
Pathogenesis of Amyloidosis
• Amyloid fibrils (AL protein or AA protein) formed in
vivo from a variety of polypeptide fragments, derived
either from immunoglobulin of plasma cell origin or
from other protein (SAA) of hepatocytic origin.
• Amyloidogenic proteins (Immunoglobulin light
chains or SAA) present in the blood is deposited in
various sites following limited proteolysis by the
action of monocyte-derived enzymes.
• Thus, mononuclear phagocyte system may play a
role by taking up immunoglobulins, Ag-Ab
complexes, or other proteins and produce necessary
polypeptides for formation of amyloid fibrils.
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
The “Beta-Sheet”, rigid folding pattern
APR-2015-CSBRP
Morphology
APR-2015-CSBRP
Specific Organ Involvement in Amyloid
Disease
• Kidney
• Liver
• Spleen
• Heart
• Lymph nodes
• Adrenal
• Thyroid
• Pituitary
• Gastrointestinal tract
• Respiratory tract
APR-2015-CSBRP
Cutaneous Amyloidosis
APR-2015-CSBRP
Skin
APR-2015-CSBRP
APR-2015-CSBRP
Bilateral periorbital
ecchymosis (raccoon eyes)
and mild proptosis.
Another example of "raccoon
eyes" which is a clinical sign of a
base of skull fracture.
APR-2015-CSBRP
APR-2015-CSBRP
Kidney in Amyloidosis
Gross: The organ is usually
enlarged and pale but a small
scarred kidney results in long
standing cases due to
secondary ischemic changes.
Micro: Amyloid is deposited
primarily in the glomeruli.
Mesengial deposition and the
deposits along basement
membrane cause capillary
narrowing and distortion of
glomerular tuft. The arterioles,
and interstitial tissue between
the tubules are also affected.
APR-2015-CSBRP
Kidney in Amyloidosis
Clinical impact:
Renal involvement in
amyloidosis is most
common and result is
nephrotic syndrome,
often as the
presenting feature. It
is the most serious
manifestation and
major cause of death.
APR-2015-CSBRP
Renal biopsy in AL amyloidosis
Staining with anti-K light chain Abs
APR-2015-CSBRP
Renal biopsy in secondary AA amyloidosis
Glomerulus is strongly positive for AA protein
APR-2015-CSBRP
Liver in Amyloidosis
Gross: Liver is enlarged,
heavy, pale, and firm.
Micro: Amyloid is deposited in
the space of Disse between the
endothelium and the liver cells,
and progressively encroaches
on adjacent hepatocytes and
sinusoids. The liver cells
undergo atrophy. Vascular
involvement and Kupffer cell
depositions are frequent.
Clinical impact: Liver
function is preserved in the
presence of marked
involvement.
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
Spleen in Amyloidosis
Gross: Spleen is enlarged and firm. Focal distribution is common.
The cut surface shows numerous translucent nodules distributed
throughout the red pulp (characteristic appearance, called ‘sago
spleen’). A diffuse type is also recognized.
Micro: In localized type amyloid is laid down in the walls of the
arterioles in the white pulp and subsequently replaces the malpighian
bodies. In diffuse type, amyloid is laid down in the walls of the
sinuses and tends to spare the follicles. Fusion of early deposits lead
to large map-like areas of amyloidosis (lardaceous spleen).APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
Cycus Revoluta
(Sago palm)
APR-2015-CSBRP
Lardaceous spleen
• fat from the abdomen of a pig, especially as
prepared for use in cooking
APR-2015-CSBRP
Lardaceous spleen
• fat from the
abdomen of a
pig, especially
as prepared for
use in cooking
APR-2015-CSBRP
Heart in Amyloidosis
Cardiac involvement is the major
manifestation of primary
amyloidosis. It occurs in multiple
myeloma and usually in elderly
people.
Gross: Heart is enlarged, rigid, and
firm.
Micro: Begin with focal
subendocardial deposition. In due
course widespread deposition of
amyloid in the walls of blood
vessels and in the interstitial tissue
surrounding and replacing muscle
fibers.
Clinical impact: Cardiomegaly with intractable heart failure. Heart block
and arrhythmia due to involvement of conduction system are common.
Condition mimicking constrictive pericarditis due to rigidity of the muscle.
APR-2015-CSBRP
CNS
APR-2015-CSBRP
Congo Red Staining of Liver in Amyloidosis
APR-2015-CSBRP
Clinical feature
APR-2015-CSBRP
Immunocyte-derived Systemic
Amyloidosis
• Found in with 5 to 15% multiple myeloma patients and in patients with
B-cell dyscrasias (monoclonal B-cell proliferations).
• Amyloid is systemic indistribution (AL type) and derived from Ig light
chains (chiefly λ type).
• An excess of corresponding light chain is usually present in the blood
and secreted in urine as Bence-Jones protein
Organ involvement and its effect:
• Kidney involvement is a major feature and usual cause of death.
• Myocardium : refractory heart failure.
• Tongue: enlargement interferes with speech.
• Esophagus: dysphagia.
• Intestine: lesions lead to obstruction, bleeding, and perforation.
• Skin: deposits cause purpura.
• Nerve: peripheral neuropathy.
• The liver, spleen, lungs, and endocrine organs are affected less
frequently.
APR-2015-CSBRP
Diagnosis
APR-2015-CSBRP
Diagnosis of Amyloid Disease in Life
• Amyloid may be demonstrated in biopsy material obtained from liver,
spleen, kidney, intestine, and bone marrow. Most common site of
biopsy is kidney, when renal manfestations are present.
• Tissue involved by amyloidosis has a tendency to bleed when
subjected to trauma. Biopsy of gingiva and rectal mucosa has
advantage over other sites in that, and should hemorrhage occur, it
can readily be controlled.
• Fine needle aspiration biopsy of the abdominal fat is also an easily
followed and extemely useful procedure for detection of systemic
amyloidosis.
• Appearance in routine stains: With light microscope and standard
tissue stains, amyloid appears as an amorphous, eosinophilic,
hyaline, extracellular substance.
• Appearance by special stain (Congo red): Amyloid stains an orange
red color under ordinary light but when the stained slide is viewed in a
polarizing microscope, a characteristic green birefringence is
imparted.
• Other investigations: In immunocyte-associated amyloidosis, serum
and urine protein electrophoresis, and immunoelectrophoresis. Bone
marrow aspiration for plasmacytosis.
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
APR-2015-CSBRP
Amyloid - Apple green birefringence
under polarized light
APR-2015-CSBRP
APR-2015-CSBRP
Demonstration of Amyloid
Stain Result Technique
Lugol’s Iodine Mahagany brown – Blue On Fresh tissue
Methyl violet Pink to Red Metachromasia
Thiflavine-T Bright red fluorescence Fluorescent technique
Thioflavine-S Bright red fluorescence Fluorescent technique
Alcian blue Green Chemical
Silver impregnantion Black Impregnation
Congo red Red Beta-pleated nature
CR + Polarization Apple green birefringens Polarization
Sirius red Green Polarization
APR-2015-CSBRP
Amyloidosis, Lugol's Reaction
APR-2015-CSBRP
APR-2015-CSBRP
E N D
APR-2015-CSBRP

More Related Content

What's hot

Benign White blood cell (WBC) Disorders
Benign White blood cell (WBC) DisordersBenign White blood cell (WBC) Disorders
Benign White blood cell (WBC) Disorders
Dr. Varughese George
 
Cell injuryadaptation 5
Cell injuryadaptation 5Cell injuryadaptation 5
Cell injuryadaptation 5
Prasad CSBR
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
ahmed mjali
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
NetanielGR
 
Amyloidosis 3
Amyloidosis 3Amyloidosis 3
Amyloidosis 3
Vijay Shankar
 
Multiple Myeloma
Multiple MyelomaMultiple Myeloma
Multiple Myeloma
Gajanan Pandit
 
Amyloidosis presentation
Amyloidosis presentationAmyloidosis presentation
Amyloidosis presentation
Harshit Saxena
 
Bone marrow biopsy and interpretation
Bone marrow biopsy and interpretationBone marrow biopsy and interpretation
Bone marrow biopsy and interpretation
sofisudha
 
Difference between reversible and irreversible cell injury,Mechanism of cell ...
Difference between reversible and irreversible cell injury,Mechanism of cell ...Difference between reversible and irreversible cell injury,Mechanism of cell ...
Difference between reversible and irreversible cell injury,Mechanism of cell ...
Rukhshanda Ramzaan
 
Dystrophy
DystrophyDystrophy
Amyloidosis
 Amyloidosis  Amyloidosis
Amyloidosis
imrana tanvir
 
AMYLOIDOSIS
AMYLOIDOSISAMYLOIDOSIS
AMYLOIDOSIS
Suraj Dhara
 
Platelet disoders
Platelet disodersPlatelet disoders
Platelet disoders
pediatricsmgmcri
 
Degeneration
DegenerationDegeneration
Degeneration
Jeny John
 
The cardiovascular system part 2
The cardiovascular system part 2The cardiovascular system part 2
The cardiovascular system part 2
Dr. Varughese George
 
Classification of Amyloidosis
Classification of AmyloidosisClassification of Amyloidosis
Classification of Amyloidosis
Abhineet Dey
 
Leukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reactionLeukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reaction
Sindhuja Yella
 
Approach to macrocytic anemia
Approach to macrocytic anemiaApproach to macrocytic anemia
Approach to macrocytic anemia
Bikal Lamichhane
 
Hereditary Spherocytosis -HS
Hereditary Spherocytosis -HSHereditary Spherocytosis -HS
Hereditary Spherocytosis -HS
DrAbdulrazzaqAlagbar
 

What's hot (20)

Amyloidoisis
AmyloidoisisAmyloidoisis
Amyloidoisis
 
Benign White blood cell (WBC) Disorders
Benign White blood cell (WBC) DisordersBenign White blood cell (WBC) Disorders
Benign White blood cell (WBC) Disorders
 
Cell injuryadaptation 5
Cell injuryadaptation 5Cell injuryadaptation 5
Cell injuryadaptation 5
 
Acute myeloid leukemia
Acute myeloid leukemiaAcute myeloid leukemia
Acute myeloid leukemia
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
 
Amyloidosis 3
Amyloidosis 3Amyloidosis 3
Amyloidosis 3
 
Multiple Myeloma
Multiple MyelomaMultiple Myeloma
Multiple Myeloma
 
Amyloidosis presentation
Amyloidosis presentationAmyloidosis presentation
Amyloidosis presentation
 
Bone marrow biopsy and interpretation
Bone marrow biopsy and interpretationBone marrow biopsy and interpretation
Bone marrow biopsy and interpretation
 
Difference between reversible and irreversible cell injury,Mechanism of cell ...
Difference between reversible and irreversible cell injury,Mechanism of cell ...Difference between reversible and irreversible cell injury,Mechanism of cell ...
Difference between reversible and irreversible cell injury,Mechanism of cell ...
 
Dystrophy
DystrophyDystrophy
Dystrophy
 
Amyloidosis
 Amyloidosis  Amyloidosis
Amyloidosis
 
AMYLOIDOSIS
AMYLOIDOSISAMYLOIDOSIS
AMYLOIDOSIS
 
Platelet disoders
Platelet disodersPlatelet disoders
Platelet disoders
 
Degeneration
DegenerationDegeneration
Degeneration
 
The cardiovascular system part 2
The cardiovascular system part 2The cardiovascular system part 2
The cardiovascular system part 2
 
Classification of Amyloidosis
Classification of AmyloidosisClassification of Amyloidosis
Classification of Amyloidosis
 
Leukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reactionLeukemoid and lekoerythroblastic reaction
Leukemoid and lekoerythroblastic reaction
 
Approach to macrocytic anemia
Approach to macrocytic anemiaApproach to macrocytic anemia
Approach to macrocytic anemia
 
Hereditary Spherocytosis -HS
Hereditary Spherocytosis -HSHereditary Spherocytosis -HS
Hereditary Spherocytosis -HS
 

Similar to 5 immunology-csbrp

Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
maha lingam
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
Charles Ntima
 
13238207.ppt
13238207.ppt13238207.ppt
13238207.ppt
ZuhaibRaza4
 
7598035.ppt
7598035.ppt7598035.ppt
7598035.ppt
SitiHajar643369
 
AMYLOIDDFHGDDSCBJUUFFFVVXFTGGVVBOSIS.pdf
AMYLOIDDFHGDDSCBJUUFFFVVXFTGGVVBOSIS.pdfAMYLOIDDFHGDDSCBJUUFFFVVXFTGGVVBOSIS.pdf
AMYLOIDDFHGDDSCBJUUFFFVVXFTGGVVBOSIS.pdf
SarithaRani4
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
SitiHajar643369
 
Recent advances in amyloidosis
Recent advances in amyloidosis   Recent advances in amyloidosis
Recent advances in amyloidosis
dhanya89
 
Amylodosis
AmylodosisAmylodosis
Amylodosis
Dr ATHUL CHANDRA.M
 
Amyloidosis
Amyloidosis Amyloidosis
Amyloidosis of kidney. Morphological characteristics, outcomes, complications
Amyloidosis of kidney. Morphological characteristics, outcomes, complicationsAmyloidosis of kidney. Morphological characteristics, outcomes, complications
Amyloidosis of kidney. Morphological characteristics, outcomes, complications
Semey State Medical University
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
Ashutosh Tiwari
 
Amyloidosis - pathophysiology (PHARM D)
Amyloidosis - pathophysiology (PHARM D)Amyloidosis - pathophysiology (PHARM D)
Amyloidosis - pathophysiology (PHARM D)
Juliya Susan Reji
 
amyloidosis 2.pdf
amyloidosis 2.pdfamyloidosis 2.pdf
amyloidosis 2.pdf
GaurishChandraRathau
 
Amyloidosis
AmyloidosisAmyloidosis
amyloidosis-160416112545 (1).pdf
amyloidosis-160416112545 (1).pdfamyloidosis-160416112545 (1).pdf
amyloidosis-160416112545 (1).pdf
DrYaqoobBahar
 
7598047.ppt
7598047.ppt7598047.ppt
7598047.ppt
SitiHajar643369
 
A my loidosis
A my loidosisA my loidosis
A my loidosis
Monika Ulamec Ulamec
 
Amyloidosis BY DR.MULLAPUDI RAMAKRISHNA
Amyloidosis BY DR.MULLAPUDI RAMAKRISHNAAmyloidosis BY DR.MULLAPUDI RAMAKRISHNA
Amyloidosis BY DR.MULLAPUDI RAMAKRISHNA
MULLAPUDI RAMAKRISHNA
 

Similar to 5 immunology-csbrp (20)

Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
 
13238207.ppt
13238207.ppt13238207.ppt
13238207.ppt
 
7598035.ppt
7598035.ppt7598035.ppt
7598035.ppt
 
AMYLOIDDFHGDDSCBJUUFFFVVXFTGGVVBOSIS.pdf
AMYLOIDDFHGDDSCBJUUFFFVVXFTGGVVBOSIS.pdfAMYLOIDDFHGDDSCBJUUFFFVVXFTGGVVBOSIS.pdf
AMYLOIDDFHGDDSCBJUUFFFVVXFTGGVVBOSIS.pdf
 
Presentation1.pptx
Presentation1.pptxPresentation1.pptx
Presentation1.pptx
 
Recent advances in amyloidosis
Recent advances in amyloidosis   Recent advances in amyloidosis
Recent advances in amyloidosis
 
Amylodosis
AmylodosisAmylodosis
Amylodosis
 
Amyloidosis
Amyloidosis Amyloidosis
Amyloidosis
 
Renal amyloidosis
Renal amyloidosisRenal amyloidosis
Renal amyloidosis
 
Amyloidosis of kidney. Morphological characteristics, outcomes, complications
Amyloidosis of kidney. Morphological characteristics, outcomes, complicationsAmyloidosis of kidney. Morphological characteristics, outcomes, complications
Amyloidosis of kidney. Morphological characteristics, outcomes, complications
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
 
Amyloidosis - pathophysiology (PHARM D)
Amyloidosis - pathophysiology (PHARM D)Amyloidosis - pathophysiology (PHARM D)
Amyloidosis - pathophysiology (PHARM D)
 
amyloidosis 2.pdf
amyloidosis 2.pdfamyloidosis 2.pdf
amyloidosis 2.pdf
 
Amyloidosis
AmyloidosisAmyloidosis
Amyloidosis
 
amyloidosis-160416112545 (1).pdf
amyloidosis-160416112545 (1).pdfamyloidosis-160416112545 (1).pdf
amyloidosis-160416112545 (1).pdf
 
7598047.ppt
7598047.ppt7598047.ppt
7598047.ppt
 
Immunopathology 6
Immunopathology 6Immunopathology 6
Immunopathology 6
 
A my loidosis
A my loidosisA my loidosis
A my loidosis
 
Amyloidosis BY DR.MULLAPUDI RAMAKRISHNA
Amyloidosis BY DR.MULLAPUDI RAMAKRISHNAAmyloidosis BY DR.MULLAPUDI RAMAKRISHNA
Amyloidosis BY DR.MULLAPUDI RAMAKRISHNA
 

More from Prasad CSBR

Acute leukemias aml-csbrp
Acute leukemias aml-csbrpAcute leukemias aml-csbrp
Acute leukemias aml-csbrp
Prasad CSBR
 
Case stuies in Lymphomas
Case stuies in LymphomasCase stuies in Lymphomas
Case stuies in Lymphomas
Prasad CSBR
 
Case studies in inflammation-1
Case studies in inflammation-1Case studies in inflammation-1
Case studies in inflammation-1
Prasad CSBR
 
Invasion &; metastasis csbrp
Invasion &; metastasis csbrpInvasion &; metastasis csbrp
Invasion &; metastasis csbrp
Prasad CSBR
 
Neoplasia introduction
Neoplasia introductionNeoplasia introduction
Neoplasia introduction
Prasad CSBR
 
Chemical safety
Chemical safety  Chemical safety
Chemical safety
Prasad CSBR
 
Single genedisorders 1
Single genedisorders 1Single genedisorders 1
Single genedisorders 1
Prasad CSBR
 
Leucocyte Disorders - Case studies
Leucocyte Disorders - Case studiesLeucocyte Disorders - Case studies
Leucocyte Disorders - Case studies
Prasad CSBR
 
Approach to endometrial biopsy
Approach to endometrial biopsyApproach to endometrial biopsy
Approach to endometrial biopsy
Prasad CSBR
 
Vit a-csbrp
Vit a-csbrpVit a-csbrp
Vit a-csbrp
Prasad CSBR
 
Cell injuryadaptation 7
Cell injuryadaptation 7Cell injuryadaptation 7
Cell injuryadaptation 7
Prasad CSBR
 
Cell injuryadaptation 6
Cell injuryadaptation 6Cell injuryadaptation 6
Cell injuryadaptation 6
Prasad CSBR
 
Cell injuryadaptation 4
Cell injuryadaptation 4Cell injuryadaptation 4
Cell injuryadaptation 4
Prasad CSBR
 
Cell injuryadaptation 3
Cell injuryadaptation 3Cell injuryadaptation 3
Cell injuryadaptation 3
Prasad CSBR
 
Cell injuryadaptation 2
Cell injuryadaptation 2Cell injuryadaptation 2
Cell injuryadaptation 2
Prasad CSBR
 
Cell injuryadaptation 1
Cell injuryadaptation 1Cell injuryadaptation 1
Cell injuryadaptation 1
Prasad CSBR
 
7 shock
7 shock7 shock
7 shock
Prasad CSBR
 
6 infarction
6 infarction6 infarction
6 infarction
Prasad CSBR
 
5 embolism
5 embolism5 embolism
5 embolism
Prasad CSBR
 
4 hemostasis&thrombosis
4 hemostasis&thrombosis4 hemostasis&thrombosis
4 hemostasis&thrombosis
Prasad CSBR
 

More from Prasad CSBR (20)

Acute leukemias aml-csbrp
Acute leukemias aml-csbrpAcute leukemias aml-csbrp
Acute leukemias aml-csbrp
 
Case stuies in Lymphomas
Case stuies in LymphomasCase stuies in Lymphomas
Case stuies in Lymphomas
 
Case studies in inflammation-1
Case studies in inflammation-1Case studies in inflammation-1
Case studies in inflammation-1
 
Invasion &; metastasis csbrp
Invasion &; metastasis csbrpInvasion &; metastasis csbrp
Invasion &; metastasis csbrp
 
Neoplasia introduction
Neoplasia introductionNeoplasia introduction
Neoplasia introduction
 
Chemical safety
Chemical safety  Chemical safety
Chemical safety
 
Single genedisorders 1
Single genedisorders 1Single genedisorders 1
Single genedisorders 1
 
Leucocyte Disorders - Case studies
Leucocyte Disorders - Case studiesLeucocyte Disorders - Case studies
Leucocyte Disorders - Case studies
 
Approach to endometrial biopsy
Approach to endometrial biopsyApproach to endometrial biopsy
Approach to endometrial biopsy
 
Vit a-csbrp
Vit a-csbrpVit a-csbrp
Vit a-csbrp
 
Cell injuryadaptation 7
Cell injuryadaptation 7Cell injuryadaptation 7
Cell injuryadaptation 7
 
Cell injuryadaptation 6
Cell injuryadaptation 6Cell injuryadaptation 6
Cell injuryadaptation 6
 
Cell injuryadaptation 4
Cell injuryadaptation 4Cell injuryadaptation 4
Cell injuryadaptation 4
 
Cell injuryadaptation 3
Cell injuryadaptation 3Cell injuryadaptation 3
Cell injuryadaptation 3
 
Cell injuryadaptation 2
Cell injuryadaptation 2Cell injuryadaptation 2
Cell injuryadaptation 2
 
Cell injuryadaptation 1
Cell injuryadaptation 1Cell injuryadaptation 1
Cell injuryadaptation 1
 
7 shock
7 shock7 shock
7 shock
 
6 infarction
6 infarction6 infarction
6 infarction
 
5 embolism
5 embolism5 embolism
5 embolism
 
4 hemostasis&thrombosis
4 hemostasis&thrombosis4 hemostasis&thrombosis
4 hemostasis&thrombosis
 

Recently uploaded

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Dr KHALID B.M
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
Rohit chaurpagar
 
The History of Diagnostic Medical imaging
The History of Diagnostic Medical imagingThe History of Diagnostic Medical imaging
The History of Diagnostic Medical imaging
Yahye Mohamed
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
Savita Shen $i11
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
Dr. Rabia Inam Gandapore
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
VarunMahajani
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
bkling
 
Questionnaire Oral Cancer research - in English.docx
Questionnaire  Oral Cancer research - in English.docxQuestionnaire  Oral Cancer research - in English.docx
Questionnaire Oral Cancer research - in English.docx
Azreen Aj
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
Levi Shapiro
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Dr KHALID B.M
 
Desidustat the rise of a new dawn - role in treatment of ckd anemia
Desidustat the rise of a new dawn - role in treatment of ckd anemiaDesidustat the rise of a new dawn - role in treatment of ckd anemia
Desidustat the rise of a new dawn - role in treatment of ckd anemia
Dr. Lalit Agarwal
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
MedicoseAcademics
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
Jim Jacob Roy
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Dr. Rabia Inam Gandapore
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
LAMPIRAN A - research proposal (oral CANCER).docx
LAMPIRAN A - research proposal (oral CANCER).docxLAMPIRAN A - research proposal (oral CANCER).docx
LAMPIRAN A - research proposal (oral CANCER).docx
Azreen Aj
 

Recently uploaded (20)

Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 UpakalpaniyaadhyayaCharaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
Charaka Samhita Sutra sthana Chapter 15 Upakalpaniyaadhyaya
 
Antiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptxAntiulcer drugs Advance Pharmacology .pptx
Antiulcer drugs Advance Pharmacology .pptx
 
The History of Diagnostic Medical imaging
The History of Diagnostic Medical imagingThe History of Diagnostic Medical imaging
The History of Diagnostic Medical imaging
 
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #GirlsFor Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Superficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptxSuperficial & Deep Fascia of the NECK.pptx
Superficial & Deep Fascia of the NECK.pptx
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
Pulmonary Thromboembolism - etilogy, types, medical- Surgical and nursing man...
 
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?
 
Questionnaire Oral Cancer research - in English.docx
Questionnaire  Oral Cancer research - in English.docxQuestionnaire  Oral Cancer research - in English.docx
Questionnaire Oral Cancer research - in English.docx
 
Prix Galien International 2024 Forum Program
Prix Galien International 2024 Forum ProgramPrix Galien International 2024 Forum Program
Prix Galien International 2024 Forum Program
 
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyayaCharaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
Charaka Samhita Sutra Sthana 9 Chapter khuddakachatuspadadhyaya
 
Desidustat the rise of a new dawn - role in treatment of ckd anemia
Desidustat the rise of a new dawn - role in treatment of ckd anemiaDesidustat the rise of a new dawn - role in treatment of ckd anemia
Desidustat the rise of a new dawn - role in treatment of ckd anemia
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
The Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of IIThe Normal Electrocardiogram - Part I of II
The Normal Electrocardiogram - Part I of II
 
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdfMANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
MANAGEMENT OF ATRIOVENTRICULAR CONDUCTION BLOCK.pdf
 
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptxTemporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
LAMPIRAN A - research proposal (oral CANCER).docx
LAMPIRAN A - research proposal (oral CANCER).docxLAMPIRAN A - research proposal (oral CANCER).docx
LAMPIRAN A - research proposal (oral CANCER).docx
 

5 immunology-csbrp

  • 2. Gist - AMYLOID • It’s only a manifestation of different diseases • it’s an abnormal protein • It’s deposited Extracellularly • It’s bland and Non-reactive • Enzyme resistant • Affects all tissues • It causes organ failure by pressure atrophy APR-2015-CSBRP
  • 3. Gist - AMYLOID Two processes are associated with such deposition • Prolonged inflammation • Excessive immunoglobulin synthesis APR-2015-CSBRP
  • 4. Amyloid Amyloid is a pathologic proteinaceous substance, deposited between cells in various tissues and organs of the body in a wide variety of clinical settings. APR-2015-CSBRP
  • 5. AmyloidAmyloid With the light microscope and standard tissue stains, amyloid appears as • An amorphous, eosinophilic, hyaline like, extracellular substance APR-2015-CSBRP
  • 6. DD Hyaline & Amyloid FeatureFeature HyalineHyaline AmyloidAmyloid Location Both extra & intracellular Extracellular Nature Protein / others Protein Inflammation Inflammatory reaction No inflammation Etiology Variety of agents Immunological H&E Eosinophilic Eosinophilic Congo red Negative Positive CR+Polarizer No change Apple green EM variety of morphology Nonbranching fibrils APR-2015-CSBRP
  • 7. Amyloid • Is not a single protein • Chemically different proteins with identical staining properties APR-2015-CSBRP
  • 8. Amyloid – Physical nature By electron microscopy:By electron microscopy: (It’s common to all amyloid proteins(It’s common to all amyloid proteins)) • Non-branching fibrils • Diameter of 7.5-10 nm • cross-β-pleated sheet conformation This β-pleated nature is responsible for its special staining character APR-2015-CSBRP
  • 9. Amyloid – Physical nature APR-2015-CSBRP
  • 10. The Nature of Amyloid Ultrastructure Structure of an amyloid fibril APR-2015-CSBRP
  • 11. Amyloid – Chemical nature Mainly composed of: 1. Fibrillary protein - 95% 2. P-component - 5% 3. Glycoprotein - a fraction APR-2015-CSBRP
  • 12. gist - The Nature of Amyloid • Physical Nature: • Electron microscopy: Amyloid material contains two components. (1) Rigid nonbranching fibrils* (7.5 to 10 nm): Constitute the major component (about 90%) (2) Pentagonal rod shaped sub-unit (P components): Forms 10% of amyloid tissue and is a glycoprotein (variable PAS positive staining). • X-ray diffraction analysis: Characteristic β-pleated configuration* in both major subtypes of amyloid. • Chemical nature: • Peptide mapping analysis of the sequence of amino acids: Of the 15 biochemically distinct forms identified, 3 are major chemical types of amyloid: (1) Amyloid of light chain origin (AL) from plasma cells, (2) Unique nonimmunoglobulin protein synthesized in the liver (AA), (3) Aβ amyloid in cerebral lesion of Alzheimer disease APR-2015-CSBRP
  • 13. Classification Amyloid may be:Amyloid may be: Systemic (generalized), involving several organ systems, or Localized, when deposits are limited to a single organ, such as the Heart, Skin et.c. APR-2015-CSBRP
  • 14. Localized Amyloid Deposits Endocrine associated: • Amyloid deposits in the stroma of medullary thyroid carcinoma, a C- cell tumor; amyloid is derived from a polypeptide hormone calcitonin. • Amyloid deposits in the stroma of islet cell tumors, particularly those producing insulin (amyloid is produced by proteolysis of insulin or its prohormone). Senile amyloidosis: • Deposits are common in the aged (seventies and eighties); found in heart (atria affected more frequently than ventricles) and brain (as senile plaques). • The plaques found in Alzheimers disease is derived from β-amyloid protein (Aβ), derived from a glycoprotein called amyloid precursor protein (APP). Other localized deposits: Microscopic deposits to nodular masses in sites such as lung, larynx, skin, bladder, and tongue. Consist of AL protein in most cases. APR-2015-CSBRP
  • 15. Clinicopathologic Category Associated Diseases Major Fibril Protein Chemically Related Precursor Protein Systemic (Generalized) Amyloidosis Immunocyte dyscrasias with amyloidosis (primary amyloidosis) Multiple myeloma and other monoclonal B-cell proliferations AL Immunoglobulin light chains, chiefly λ type Reactive systemic amyloidosis (secondary amyloidosis) Chronic inflammatory conditions AA SAA Hemodialysis-associated amyloidosis Chronic renal failure Aβ2 m β2 -microglobulin Hereditary amyloidosis Familial Mediterranean fever — AA SAA Familial amyloidotic neuropathies (several types) — ATTR Transthyretin Systemic senile amyloidosis — ATTR Transthyretin Localized Amyloidosis Senile cerebral Alzheimer disease Aβ APP Endocrine Medullary carcinoma of thyroid — A Cal Calcitonin Islet of Langerhans Type II diabetes AIAPP Islet amyloid peptide Isolated atrial amyloidosis — AANF Atrial natriuretic factor Prion diseases Various prion diseases of the CNS Misfolded prion protein (PrPSC ) Normal prion protein PrP APR-2015-CSBRP
  • 16. Classification of Systemic AmyloidosisClassification of Systemic Amyloidosis on clinical groundson clinical grounds • Primary amyloidosis, when associated with some immunocyte dyscrasia, or • Secondary amyloidosis, when it occurs as a complication of an underlying chronic inflammatory or tissue destructive process. • Hereditary or familial amyloidosis constitutes a separate, albeit heterogeneous group, with several distinctive patterns of organ involvement. • Hemodialysis associated Amyloidosis • Localized amyloidosis - (A). Endocrine associated, (B). Senile, and (C). Others APR-2015-CSBRP
  • 17. Immunocyte Dyscrasias with Amyloidosis (Primary Amyloidosis) • Most common form of amyloidosis • many of these patients have some form of plasma cell dyscrasia / B-cell dyscrasia • Amyloid has AL composition APR-2015-CSBRP
  • 18. Reactive Systemic Amyloidosis • Secondary to an inflammatory condition • Protracted breakdown of cells • Composed of AA protein Chronic osteomyelitis Rheumatoid arthritis Bronchiectasis Connective tissue disease Tuberculosis RCC Leprosy Hodgkin’s disease APR-2015-CSBRP
  • 19. Patients on long-term hemodialysis for renal failure High β2-microglobulin in the serum Amyloid deposits in the synovium, joints, and tendon sheaths Hemodialysis-Associated Amyloidosis APR-2015-CSBRP
  • 20. • Many familial forms of amyloidosis • Confined to limited geographic areas • The most common is familial Mediterranean fever • Others - familial amyloidotic polyneuropathies Heredofamilial Amyloidosis APR-2015-CSBRP
  • 21. Microscopic localized deposits of amyloid in endocrine tumors, Eg: Medullary carcinoma of the thyroid gland, Islet tumors of the pancreas Pheochromocytomas and Undifferentiated carcinomas of the stomach Amyloid derived from hormones or unique proteins Endocrine Amyloid APR-2015-CSBRP
  • 22. Several well-documented forms of amyloid deposition occur with aging Senile systemic amyloidosis - systemic deposition of amyloid in elderly patients called senile cardiac amyloidosis Amyloid of Aging APR-2015-CSBRP
  • 23. Amyloid – Chemical nature Fibrillary component: 15 bio-chemically distinct forms have been identified Three are most common: (1) AL (amyloid light chain) immunoglobulin light chains (2) AA (amyloid-associated) nonimmunoglobulin protein synthesized by the liver and (3) Aβ amyloid is found in Alzheimer disease APR-2015-CSBRP
  • 24. Proposed Scheme of Pathogenesis of Two Major Forms of Amyloid Fibrils APR-2015-CSBRP
  • 25. Pathogenesis of Amyloidosis • Amyloid fibrils (AL protein or AA protein) formed in vivo from a variety of polypeptide fragments, derived either from immunoglobulin of plasma cell origin or from other protein (SAA) of hepatocytic origin. • Amyloidogenic proteins (Immunoglobulin light chains or SAA) present in the blood is deposited in various sites following limited proteolysis by the action of monocyte-derived enzymes. • Thus, mononuclear phagocyte system may play a role by taking up immunoglobulins, Ag-Ab complexes, or other proteins and produce necessary polypeptides for formation of amyloid fibrils. APR-2015-CSBRP
  • 28. The “Beta-Sheet”, rigid folding pattern APR-2015-CSBRP
  • 30. Specific Organ Involvement in Amyloid Disease • Kidney • Liver • Spleen • Heart • Lymph nodes • Adrenal • Thyroid • Pituitary • Gastrointestinal tract • Respiratory tract APR-2015-CSBRP
  • 34. Bilateral periorbital ecchymosis (raccoon eyes) and mild proptosis. Another example of "raccoon eyes" which is a clinical sign of a base of skull fracture. APR-2015-CSBRP
  • 36. Kidney in Amyloidosis Gross: The organ is usually enlarged and pale but a small scarred kidney results in long standing cases due to secondary ischemic changes. Micro: Amyloid is deposited primarily in the glomeruli. Mesengial deposition and the deposits along basement membrane cause capillary narrowing and distortion of glomerular tuft. The arterioles, and interstitial tissue between the tubules are also affected. APR-2015-CSBRP
  • 37. Kidney in Amyloidosis Clinical impact: Renal involvement in amyloidosis is most common and result is nephrotic syndrome, often as the presenting feature. It is the most serious manifestation and major cause of death. APR-2015-CSBRP
  • 38. Renal biopsy in AL amyloidosis Staining with anti-K light chain Abs APR-2015-CSBRP
  • 39. Renal biopsy in secondary AA amyloidosis Glomerulus is strongly positive for AA protein APR-2015-CSBRP
  • 40. Liver in Amyloidosis Gross: Liver is enlarged, heavy, pale, and firm. Micro: Amyloid is deposited in the space of Disse between the endothelium and the liver cells, and progressively encroaches on adjacent hepatocytes and sinusoids. The liver cells undergo atrophy. Vascular involvement and Kupffer cell depositions are frequent. Clinical impact: Liver function is preserved in the presence of marked involvement. APR-2015-CSBRP
  • 43. Spleen in Amyloidosis Gross: Spleen is enlarged and firm. Focal distribution is common. The cut surface shows numerous translucent nodules distributed throughout the red pulp (characteristic appearance, called ‘sago spleen’). A diffuse type is also recognized. Micro: In localized type amyloid is laid down in the walls of the arterioles in the white pulp and subsequently replaces the malpighian bodies. In diffuse type, amyloid is laid down in the walls of the sinuses and tends to spare the follicles. Fusion of early deposits lead to large map-like areas of amyloidosis (lardaceous spleen).APR-2015-CSBRP
  • 48. Lardaceous spleen • fat from the abdomen of a pig, especially as prepared for use in cooking APR-2015-CSBRP
  • 49. Lardaceous spleen • fat from the abdomen of a pig, especially as prepared for use in cooking APR-2015-CSBRP
  • 50. Heart in Amyloidosis Cardiac involvement is the major manifestation of primary amyloidosis. It occurs in multiple myeloma and usually in elderly people. Gross: Heart is enlarged, rigid, and firm. Micro: Begin with focal subendocardial deposition. In due course widespread deposition of amyloid in the walls of blood vessels and in the interstitial tissue surrounding and replacing muscle fibers. Clinical impact: Cardiomegaly with intractable heart failure. Heart block and arrhythmia due to involvement of conduction system are common. Condition mimicking constrictive pericarditis due to rigidity of the muscle. APR-2015-CSBRP
  • 52. Congo Red Staining of Liver in Amyloidosis APR-2015-CSBRP
  • 54. Immunocyte-derived Systemic Amyloidosis • Found in with 5 to 15% multiple myeloma patients and in patients with B-cell dyscrasias (monoclonal B-cell proliferations). • Amyloid is systemic indistribution (AL type) and derived from Ig light chains (chiefly λ type). • An excess of corresponding light chain is usually present in the blood and secreted in urine as Bence-Jones protein Organ involvement and its effect: • Kidney involvement is a major feature and usual cause of death. • Myocardium : refractory heart failure. • Tongue: enlargement interferes with speech. • Esophagus: dysphagia. • Intestine: lesions lead to obstruction, bleeding, and perforation. • Skin: deposits cause purpura. • Nerve: peripheral neuropathy. • The liver, spleen, lungs, and endocrine organs are affected less frequently. APR-2015-CSBRP
  • 56. Diagnosis of Amyloid Disease in Life • Amyloid may be demonstrated in biopsy material obtained from liver, spleen, kidney, intestine, and bone marrow. Most common site of biopsy is kidney, when renal manfestations are present. • Tissue involved by amyloidosis has a tendency to bleed when subjected to trauma. Biopsy of gingiva and rectal mucosa has advantage over other sites in that, and should hemorrhage occur, it can readily be controlled. • Fine needle aspiration biopsy of the abdominal fat is also an easily followed and extemely useful procedure for detection of systemic amyloidosis. • Appearance in routine stains: With light microscope and standard tissue stains, amyloid appears as an amorphous, eosinophilic, hyaline, extracellular substance. • Appearance by special stain (Congo red): Amyloid stains an orange red color under ordinary light but when the stained slide is viewed in a polarizing microscope, a characteristic green birefringence is imparted. • Other investigations: In immunocyte-associated amyloidosis, serum and urine protein electrophoresis, and immunoelectrophoresis. Bone marrow aspiration for plasmacytosis. APR-2015-CSBRP
  • 61. Amyloid - Apple green birefringence under polarized light APR-2015-CSBRP
  • 63. Demonstration of Amyloid Stain Result Technique Lugol’s Iodine Mahagany brown – Blue On Fresh tissue Methyl violet Pink to Red Metachromasia Thiflavine-T Bright red fluorescence Fluorescent technique Thioflavine-S Bright red fluorescence Fluorescent technique Alcian blue Green Chemical Silver impregnantion Black Impregnation Congo red Red Beta-pleated nature CR + Polarization Apple green birefringens Polarization Sirius red Green Polarization APR-2015-CSBRP

Editor's Notes

  1. Figure 6-53  Structure of an amyloid fibril, depicting the β-pleated sheet structure and binding sites for the Congo red dye, which is used for diagnosis of amyloidosis.  (Modified from Glenner GG: Amyloid deposit and amyloidosis. The β-fibrilloses. N Engl J Med 52:148, 1980. By permission of The New England Journal of Medicine.)
  2. Figure 6-53  Structure of an amyloid fibril, depicting the β-pleated sheet structure and binding sites for the Congo red dye, which is used for diagnosis of amyloidosis.  (Modified from Glenner GG: Amyloid deposit and amyloidosis. The β-fibrilloses. N Engl J Med 52:148, 1980. By permission of The New England Journal of Medicine.)
  3. *responsible for unique staining and biological properties (e. g., orange red staining under ordinary light and apple green birefringence while examined under polarized light after Congo red staining).
  4. On clinical grounds, the systemic, or generalized, pattern is subclassified into primary amyloidosis, when associated with some immunocyte dyscrasia, or secondary amyloidosis, when it occurs as a complication of an underlying chronic inflammatory or tissue destructive process. Hereditary or familial amyloidosis constitutes a separate, albeit heterogeneous group, with several distinctive patterns of organ involvement. Immunocyte Dyscrasias with Amyloidosis (Primary Amyloidosis). Hemodialysis associated Amyloidosis Localized amyloidosis - (A). Endocrine associated, (B). Senile, and (C). Others
  5. Immunocyte Dyscrasias with Amyloidosis (Primary Amyloidosis). Amyloid in this category is usually systemic in distribution and is of the AL type. With approximately 1275 to 3200 new cases every year in the United States, this is the most common form of amyloidosis. In many of these cases, the patients have some form of plasma cell dyscrasia. Best defined is the occurrence of systemic amyloidosis in 5% to 15% of patients with multiple myeloma, a plasma-cell tumor characterized by multiple osteolytic lesions throughout the skeletal system ( Chapter 14 ). The malignant B cells characteristically synthesize abnormal amounts of a single specific immunoglobulin (monoclonal gammopathy), producing an M (myeloma) protein spike on serum electrophoresis. In addition to the synthesis of whole immunoglobulin molecules, only the light chains (referred to as Bence Jones protein) of either the λ or the κ variety may be elaborated and found in the serum. By virtue of the small molecular size of the Bence Jones protein, it is frequently excreted in the urine. The amyloid deposits contain the same light chain protein. Almost all the patients with myeloma who develop amyloidosis have Bence Jones proteins in the serum or urine, or both, but a great majority of myeloma patients who have free light chains do not develop amyloidosis. Clearly, therefore, the presence of Bence Jones proteins, although necessary, is by itself not enough to produce amyloidosis. We discuss later the other factors, such as the type of light chain produced (amyloidogenic potential) and the subsequent handling (possibly degradation) that may have a bearing on whether Bence Jones proteins are deposited as amyloid. The great majority of patients with AL amyloid do not have classic multiple myeloma or any other overt B-cell neoplasm; such cases have been traditionally classified as primary amyloidosis because their clinical features derive from the effects of amyloid deposition without any other associated disease. In virtually all such cases, however, monoclonal immunoglobulins or free light chains, or both, can be found in the serum or urine. Most of these patients also have a modest increase in the number of plasma cells in the bone marrow, which presumably secrete the precursors of AL protein. Clearly, these patients have an underlying B-cell dyscrasia in which production of an abnormal protein, rather than production of tumor masses, is the predominant manifestation. Recent studies have revealed chromosomal translocations in many of these patients, suggesting the presence of neoplastic clones.[171] Whether most of these clones would evolve into myeloma if the patients lived long enough can only be a matter for speculation.
  6. Reactive Systemic Amyloidosis. The amyloid deposits in this pattern are systemic in distribution and are composed of AA protein. This category was previously referred to as secondary amyloidosis because it is secondary to an associated inflammatory condition. The feature common to most of the conditions associated with reactive systemic amyloidosis is protracted breakdown of cells resulting from a wide variety of infectious and noninfectious chronic inflammatory conditions. At one time, tuberculosis, bronchiectasis, and chronic osteomyelitis were the most important underlying conditions, but with the advent of effective antimicrobial chemotherapy, the importance of these conditions has diminished. More commonly now, reactive systemic amyloidosis complicates rheumatoid arthritis, other connective tissue disorders such as ankylosing spondylitis, and inflammatory bowel disease, particularly Crohn disease and ulcerative colitis. Among these, the most frequent associated condition is rheumatoid arthritis. Amyloidosis is reported to occur in approximately 3% of patients with rheumatoid arthritis and is clinically significant in one half of those affected. Heroine abusers who inject the drug subcutaneously also have a high occurrence rate of generalized AA amyloidosis. The chronic skin infections associated with "skin-popping" of narcotics seem to be responsible for amyloidosis in this group of patients. Reactive systemic amyloidosis may also occur in association with non-immunocyte-derived tumors, the two most common being renal cell carcinoma and Hodgkin disease.
  7. Hemodialysis-Associated Amyloidosis. Patients on long-term hemodialysis for renal failure develop amyloidosis owing to deposition of β2-microglobulin. This protein is present in high concentrations in the serum of patients with renal disease and is retained in circulation because it cannot be filtered through the cuprophane dialysis membranes. In some series, as many as 60% to 80% of the patients on long-term dialysis developed amyloid deposits in the synovium, joints, and tendon sheaths.
  8. Heredofamilial Amyloidosis. A variety of familial forms of amyloidosis have been described. Most of them are rare and occur in limited geographic areas. The most common and best studied is an autosomal recessive condition called familial Mediterranean fever.[172] This is a febrile disorder of unknown cause characterized by attacks of fever accompanied by inflammation of serosal surfaces, including peritoneum, pleura, and synovial membrane. This disorder is encountered largely in individuals of Armenian, Sephardic Jewish, and Arabic origins. It is associated with widespread tissue involvement indistinguishable from reactive systemic amyloidosis. The amyloid fibril proteins are made up of AA proteins, suggesting that this form of amyloidosis is related to the recurrent bouts of inflammation that characterize this disease. The gene for familial Mediterranean fever has been cloned, and its product is called pyrin (for its relation to fever). Although its exact function is not known, it has been suggested that pyrin is responsible for regulating acute inflammation, presumably by inhibiting the function of neutrophils.[173] The relationship of this mutation to the disease is not understood. In contrast to familial Mediterranean fever, a group of autosomal dominant familial disorders is characterized by deposition of amyloid predominantly in the nerves—peripheral and autonomic. These familial amyloidotic polyneuropathies have been described in different parts of the world. As mentioned previously, in all of these genetic disorders, the fibrils are made up of mutant transthyretins (ATTR).
  9. Endocrine Amyloid. Microscopic deposits of localized amyloid may be found in certain endocrine tumors, such as medullary carcinoma of the thyroid gland, islet tumors of the pancreas, pheochromocytomas, and undifferentiated carcinomas of the stomach, and in the islets of Langerhans in patients with type II diabetes mellitus. In these settings, the amyloidogenic proteins seem to be derived either from polypeptide hormones (e.g., medullary carcinoma) or from unique proteins (e.g., islet amyloid polypeptide).
  10. Amyloid of Aging. Several well-documented forms of amyloid deposition occur with aging.[174] Senile systemic amyloidosis refers to the systemic deposition of amyloid in elderly patients (usually in their seventies and eighties). Because of the dominant involvement and related dysfunction of the heart, this form was previously called senile cardiac amyloidosis. Those who are symptomatic present with a restrictive cardiomyopathy and arrhythmias. The amyloid in this form is composed of the normal TTR molecule. In addition to the sporadic senile systemic amyloidosis, another form, affecting predominantly the heart, that results from the deposition of a mutant form of TTR has also been recognized. Approximately 4% of the black population in the United States is a carrier of the mutant allele, and cardiomyopathy has been identified in both homozygous and heterozygous patients. The precise prevalance of patients with this mutation who develop clinically manifest cardiac disease is not known.
  11. Figure 6-53  Structure of an amyloid fibril, depicting the β-pleated sheet structure and binding sites for the Congo red dye, which is used for diagnosis of amyloidosis.  (Modified from Glenner GG: Amyloid deposit and amyloidosis. The β-fibrilloses. N Engl J Med 52:148, 1980. By permission of The New England Journal of Medicine.)
  12. Direct dermal infiltration can produce subcutaneous nodules and plaques. Classically described as smooth, waxy, yellowish lesions, these are uncommon and more often appear hemorrhagic. They are generally found on flexor surfaces, the face, and the buccal mucosa (Fig. 2). Cutaneous nodules can be demonstrated to follow the path of blood vessels within the skin [2]. Direct skin infiltration with amyloid can produce the appearance of scleroderma on the face, hands, and feet. Rarely, infiltrative nodular lesions may coalesce to form gross distortion and enlargement or tumefaction
  13. Purpura, petechiae, and ecchymoses occur commonly in the skin and mucous membranes. They are due to intracutaneous hemorrhage, the result of amyloid infiltrating and weakening blood-vessel walls. These lesions may occur spontaneously and are particularly common in skin folds such as the eyelids, axillae, umbilicus, and anogenital area. Periorbital purpura may arise after coughing, sneezing, performing proctoscopy, or the valsalva maneuver --------------------------- Direct dermal infiltration can produce subcutaneous nodules and plaques. Classically described as smooth, waxy, yellowish lesions, these are uncommon and more often appear hemorrhagic. They are generally found on flexor surfaces, the face, and the buccal mucosa (Fig. 2). Cutaneous nodules can be demonstrated to follow the path of blood vessels within the skin [2]. Direct skin infiltration with amyloid can produce the appearance of scleroderma on the face, hands, and feet. Rarely, infiltrative nodular lesions may coalesce to form gross distortion and enlargement or tumefaction
  14. Raccoon Eyes: A I5-month-old girl was admitted to hospital with the complaints of bruising around the eyes for 10 days. She had one month history of abdominal pain and accompanied by fever and vomiting for one week. Physical examination demonstrated pallor, periorbital ecchymoses (raccoon eyes) and bilaterally mild proptosis (Fig. 1). She also had a left sided abdominal mass, which was 5 × 8 cm in diameter. The laboratory investigation revealed hemoglobin level 6g/dL, white cell count 10,000/mm3 and platelet count 34,000/mm3. Urinary vanillymandelic acid level was high. Bilateral bone marrow aspiration revealed infiltration with neuroblasts. Abdominal CT showed a left supra-renal mass (5 × 7 cm in diameter), which was diagnosed as a neuroblastoma on histopathologic examination. The metastatic involvement of the periorbital tissues. has been described and the resultant proptosis and orbital ecchymosis has been given the tag of ‘raccoon eyes’. Orbital metastases can be found in up to 20% of children with stage IV neuroblastoma. The raccoon eyes appearance associated with neuroblastoma is probably related to obstruction of the palpebral vessels by tumor tissue in and around the orbis. There are a multitude of differential diagnoses for the presentation of periorbital edema and ecchymosis, e.g., child abuse or trauma, infection of the soft tissues associated with a spreading dental infection and an allergic reaction. Other systemic causes to be considered include myxoedema, other neoplasias such as lymphoma or haematological coagulopathies such as haemophilia.
  15. Notice the large hyaline masses arranged diagonally across the screen. The upper left and the lower right areas of the field are occupied by normal white pulp. Amyloidosis of the spleen is seen in two forms - the sago spleen in which amyloid depositis are limited to the follicles, and the lardaceous spleen in which amyloid is deposited in the walls of the splenic sinusoids and spares the follicles. It is not clear which form is seen in this picture.
  16. Notice the large hyaline masses arranged diagonally across the screen. The upper left and the lower right areas of the field are occupied by normal white pulp. Amyloidosis of the spleen is seen in two forms - the sago spleen in which amyloid depositis are limited to the follicles, and the lardaceous spleen in which amyloid is deposited in the walls of the splenic sinusoids and spares the follicles. It is not clear which form is seen in this picture.
  17. (A) The amyloid appears pink and is localized to the perifollicular zone. (B) The identical area exhibits green birefringence in polarized light. Amyloid is indicated by arrows.
  18. Lugol’s Iodine: Mahagany brown, and treatment with 10% H2SO4 turns blue. 1% aqueous Methyl violet (5minutes) and differentiated with 1% acetic acid – Oink to red Sirius red: similar to congo red. It’s an alternative. Toludene blue: Dark red polariazation. Thioflavine-T&S: bright red fluorescenece Alcian blue: green. Cong red: red with polarized light, apple green birefringence.
  19. Amyloidosis, Lymphnode, Lugol's Reaction: left: Positive Lugol reaction in node with amyloidosis. right: Negative Lugol reaction in normal myometrium. A slice of the affected node (left) was treated for less than a minute in Lugol's solution. At right is a piece of normal myometrium treated similarly. The amyloid in the node reacts so strongly, it is almost black.